Loading...
Last update:  October 15, 2017
12:47 +1GMT

Allergenic Molecule  Hev b 8Homo sapiens  
Epidemiology from Literature
CohortYearCountryTestSubjectsPositive (%)Bibliography
3.2.1 - Source Sensitized (IgE)2009ItalyIgE7100.00020091030, Quercia O
4.1.5 - Heterologous Source Sensitized (IgE)2011ItalyIgE4395.35020110214, Villalta D
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2002SpainSPT3193.500
3.2.1 - Source Sensitized (IgE)2009BelgiumIgE2075.00020091121, Ebo DG
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2002SpainIgE3141.900
1.11 - Esophagitis, Diagnosed2013SwitzerlandIgE3540.00020130605, Simon D
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2002SpainIgE (IB)3132.200
5.3.1 - Source Exposed (Symptoms, IgE)2010GermanyIgE5230.77020100423, Ott H
5.3.1 - Source Exposed (Symptoms, IgE)2001GermanyIgE5024.000
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2010Italy / Austria / Switzerland / NetherlandsIgE4820.83020101118, Bublin M
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2012FranceIgE9719.00020120706, Garnier L
4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE)2009BelgiumIgE3718.91020090826, Ebo DG
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2010Italy / Austria / Switzerland / NetherlandsIgE10118.81020101118, Bublin M
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2006SpainIgE2317.40020060324, Sanz ML
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2000GermanyIgE4216.700
5.3.1 - Source Exposed (Symptoms, IgE)2012BelgiumIgE9916.16020110223, De Knop KJ
4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE)2014SpainIgE13015.60020140401, Armentia A
4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE)2012SpainIgE5514.50020120726, Pedrosa M
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2009JapanIgE1414.20020090520, Yagami A
6.5 - Occupational Exposure2012South AfricaIgE8514.18020120404, Singh T
1.11 - Esophagitis, Diagnosed2014SpainIgE6713.40020140625, Armentia A
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2009JapanSPT1413.30020090520, Yagami A
4.1.8 - Heterologous Source Sensitized (SPT, IgE)2012SpainIgE6813.20020120726, Pedrosa M
1.5 - Atopic Dermatitis, Diagnosed2009GermanyIgE2010.00020091005, Ott H
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2013BrazilIgE119.09020130429, Bueno de Sa A
1.11 - Esophagitis, Diagnosed2013NetherlandsIgE767.90020131020, van Rhijn BD
1.10 - Any allergy symptom, Diagnosed2010BelgiumIgE866.97620101214, Gadisseur R
1.5 - Atopic Dermatitis, Diagnosed2013GermanyIgE1406.43020130111, Ott H
1.10 - Any allergy symptom, Diagnosed2010ItalyIgE164086.21020100301, Scala E
5.3.1 - Source Exposed (Symptoms, IgE)2001GermanyIgE345.900
5.3.1 - Source Exposed (Symptoms, IgE)2009BelgiumIgE224.55020091121, Ebo DG
1.9 - Pollen Allergy2014SpainIgE504.00020140625, Armentia A
5.2.1 - Source Exposed (Symptoms, SPT)2000CanadaSPT293.400
1.2.1 - Asthma, Diagnosed (Adults)2012SwedenIgE963.13020120528, Patelis A
6.2 - General Population (Adults)2012SwedenIgE3711.08020120528, Patelis A
1.1 - Asymptomatic2009BelgiumIgE260.00020091121, Ebo DG
1.1 - Asymptomatic2014SpainIgE500.00020140625, Armentia A
10.1 - Normal Control2012BelgiumIgE270.00020110223, De Knop KJ
4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE)2009ItalyIgE210.00020090808, Krause S
5.3.1 - Source Exposed (Symptoms, IgE)2008PortugalIgE50.00020080904, Rodrigues Alves R
5.3.1 - Source Exposed (Symptoms, IgE)2005SpainIgE310.000
Developed by
Panservice